Th2-lymphocyte factor-induced inflammation disease can be regulated by IL-25 and Tslp which promote the initiation of Th2 inflammation in airway mucosa, through facilitating Th2-cell proliferation and differentiation as well as activating group 2 innate lymphoid cells [27–29]. The gene discussed is IL25; the disease is inflammatory response.